Further studies in progress recommend that ARV-825 might also be effective in maximizing the reaction to estrogen deprivation (aromatase inhibition), another part of normal of treatment in ER+ breast cancer. 88 These preclinical studies provide paradigms for long run clinical trials in AML, and u